Literature DB >> 21302016

A prehospital acute coronary syndrome in a cocaine user: an unstable clinical situation.

Nicolas Franchitto1, Claudine Cabot, Nicolas Dumonteil, Vincent Bounes, Atul Pathak, Daniel Rougé.   

Abstract

Chest pain is a common reason why cocaine-addicted patients call the emergency department, and acute coronary syndromes are difficult to diagnose in these situations. A 30-year-old cocaine-user patient contacts the Emergency Medical Assistance Service with constrictive chest pain. A doctor is sent out to the patient at home. The initial ECG is normal. No other aetiology of chest pain is revealed, except nicotine and cocaine addictions. First, a coronary artery spasm is suggested, caused by the injection of cocaine. During the journey, the patient indicates that the chest pain has returned. A 12-lead ECG shows repolarisation abnormality in the form of a subepicardial ischaemia. Fibrinolysis is not prescribed in view of the patient's history and of the proximity of the interventional cardiology team. The coronary angiogram enables the diagnosis of myocardial bridging in the middle anterior interventricular artery, and no significant lesion of the coronary arteries is noted. A particular feature of prehospital management in France is that medical care can be given in the early stages by a physician who is called by the patient. This case report discusses the specific care requirements of which the emergency physician needs to be aware in the context of this unstable clinical situation due to the urgency associated with the difficulties of ECG diagnosis of ST-segment elevation in cocaine users.

Entities:  

Mesh:

Year:  2012        PMID: 21302016      PMCID: PMC3550224          DOI: 10.1007/s13181-011-0137-7

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  7 in total

Review 1.  Evaluation and management of the patient who has cocaine-associated chest pain.

Authors:  Judd E Hollander; Timothy D Henry
Journal:  Cardiol Clin       Date:  2006-02       Impact factor: 2.213

2.  Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.

Authors:  Philip B Dattilo; Susan M Hailpern; Kerrie Fearon; Davendra Sohal; Charles Nordin
Journal:  Ann Emerg Med       Date:  2007-06-20       Impact factor: 5.721

3.  Cocaine and beta-blockers: should the controversy continue?

Authors:  Robert S Hoffman
Journal:  Ann Emerg Med       Date:  2007-09-24       Impact factor: 5.721

Review 4.  Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology.

Authors:  James McCord; Hani Jneid; Judd E Hollander; James A de Lemos; Bojan Cercek; Priscilla Hsue; W Brian Gibler; E Magnus Ohman; Barbara Drew; George Philippides; L Kristin Newby
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

5.  Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil.

Authors:  B H Negus; J E Willard; L D Hillis; D B Glamann; C Landau; R W Snyder; R A Lange
Journal:  Am J Cardiol       Date:  1994-03-01       Impact factor: 2.778

6.  Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin.

Authors:  W C Brogan; R A Lange; A S Kim; D J Moliterno; L D Hillis
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.